NEW YORK, Dec 19 – Motorola said Tuesday it had reached an agreement to exclusively license Molecular Staging’s Rolling Circle Amplification Technology for use in its diagnostic nucleic acid bioarrays, marking Motorola’s fourth genomics collaboration as it attempts to gain a foothold in the burgeoning market.

In exchange for the technology, Motorola will pay a licensing fee as well as make equity investments in Molecular Staging. Motorola also received an option to increase its stake in the future.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.